Molecular mechanisms of corticosteroid actions

Monaldi Archives for Chest Disease

Volumn 55, Issue 3, 2000, Pages 256-266

  Adcock, I M ^a   Ito, K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chromatin structure; Glucocorticoids; Histone acetylation; Inflammation; Transcription factors

Indexed keywords

CELL ADHESION MOLECULE; CORTICOSTEROID; CYTOKINE; ENZYME; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOCORTIN; NUCLEAR FACTOR; PROTEINASE INHIBITOR; RECEPTOR; VERY LATE ACTIVATION ANTIGEN 1;

ASTHMA; CHROMATIN STRUCTURE; DRUG ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033883117     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Efficacy of inhaled corticosteroids in asthma
2. Inhaled glucocorticoids for asthma
3. Glucocorticoid effects on the production and actions of immune cytokines
4. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes
5. Inhibition of interleukin-5 gene expression by dexamethasone
6. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
7. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: Differential sensitivity of GM-CSF, IL-1 beta, and IL-6
8. Dexamethasome inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms
9. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation
10. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes
11. Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells
12. Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands
13. The pharmacology of apoptosis
14. Glucocorticoids inhibit cytokine-mediated eosinophil survival
15. Blood eosinophil numbers and activity during 24 hours: Effects of treatment with budesonide and bambuterol
16. Cell cycle regulation and apoptosis
17. Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis
18. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids
19. Control of transcription by steroid hormones
20. Glucocorticoid receptor localization in normal and asthmatic lung
21. Glucocorticoid receptors in bronchial epithelial cells in asthma
22. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system
23. Functional domains of the human glucocorticoid receptor
24. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
25. Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor
26. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex
27. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
28. Reduced levels of hsp90 compromise steroid receptor action in vivo
29. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene
30. Role of TATA-element in transcription from glucocorticoid receptor-responsive model promoters
31. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
32. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
33. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids
34. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis
35. I-kappaB alpha independent downregulation of NF-kappaB activity by glucocorticoid receptor
36. Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells
37. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucocorticoids) inhibit G protein-dependent activation of cPLA2 activity
38. Human recombinant lipocortin 1 (annexin 1) has anticoagulant activity on human plasma in vitro
39. Lipocortin-1: Cellular mechanisms and clinical relevance
40. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line
41. Diversity of group types, regulation, and function of phospholipase A2
42. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids
43. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung
44. Protective effects of a glucocorticoid on down-regulation of pulmonary beta 2-adrenergic receptors in vivo
45. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4
46. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line
47. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts
48. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor
49. Pharmacology of the eosinophil
50. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene
51. Transcriptional control. Sinful repression
52. Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin
53. Transcription: Gene control by targeted histone acetylation
54. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
55. Different histone acetylation induced by glucocorticoids and IL-1β in human epithelial cells (A549)
56. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glycocorticoid hormone
57. Nuclear receptor/AP-1 interaction
58. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor
59. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
60. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung
61. STAT3 acts as a co-activator of glucocorticoid receptor signaling
62. Functional interactions between Stat5 and the glucocorticoid receptor
63. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells
64. The transcriptional coactivators p300 and CBP are histone acetyltransferases
65. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells
66. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
67. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
68. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling
69. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator
70. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
71. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response
72. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling
73. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
74. Glucocorticoid receptor down-regulates c-jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures
75. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
76. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells
77. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells
78. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
79. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA
80. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells
81. Expression of RANTES in human airway epithelial cells: Effect of corticosteroids and interleukin-4, -10 and -13
82. Expression of RANTES by human bronchial epithelial cells in vitro and in vitro and in vivo and the effect of corticosteroids
83. Genomic organization and transcriptional regulation of the RANTES chemokine gene
84. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1
85. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: Preferential targetting of NF-kB and lack of I-kb involvement
86. Synthetic glycocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
87. DNA binding of the glucocorticoid receptor is not essential for survival
88. Steroid resistance in asthma
89. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
90. IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-production by human mononuclear blood cells
91. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma
92. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma
93. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes
94. Increased JUN kinase activity in peripheral blood monocytes from steroid-resistant asthmatic subjects
95. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma
96. Regulation of glucocorticoid receptor expression
97. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids
98. Decreased glycocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection
99. Transcription factors: A new frontier in drug discovery
100. Cyclosporin A and glucocorticoids interact synergistically in T-lymphocytes: Implications for asthma therapy
101. IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1 beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway
102. The immunosuppressive fungal metabolise gliotoxin specifically inhibits transcription factor NF-KappaB
103. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN)